CCND1 and breast carcinoma: Researches about new prognostic markers in breast cancer are currently in progress and provide a huge amount of information in terms of better understanding the tumor microenvironment44 and the gene signature.45 However, the prognostic value of cyclin D1 overexpression in breast cancer is controversial and needs further investigations.